IMM-1-104
immuneering
['imm-1-104', 'immuneering']
immuneering announces positive initial phase 1 pharmacokinetic, pharmacodynamic and safety data for imm-1-104 universal-ras program; accelerates study timeline - presented at aacr annual meeting support imm-1-104's potential to address a broad populatio... 
CEO Of Digital Media Online